HIMSS25: FDB to Spotlight Customer Success Stories and Innovative Drug Knowledge Solutions

News provided by

Feb 26, 2025, 10:00 ET

From Integrating Real-Time Pharmacogenomics to Boosting Medication Adherence, Healthcare Organizations Are Realizing the Benefits of Advanced Medication Decision Support

SOUTH SAN FRANCISCO, Calif., Feb. 26, 2025 /PRNewswire/ -- FDB (First Databank, Inc.), the leading provider of drug knowledge that helps healthcare professionals make precise medication decisions, will shine a spotlight on their many customer success stories and enhanced innovative solutions at the 2025 HIMSS Global Health Conference & Exhibition in Las Vegas from March 3-6.

At FDB booth #2835 in the HIMSS25 exhibit hall, HIMSS25 attendees will have an opportunity to learn how physicians, pharmacists, nursing and clinical informatics leaders are improving patients' health and safety and delivering high-quality care through the integration of FDB's trusted drug knowledge and next-generation medication decision support, patient education, and ePrescribing network solutions that consider the unique circumstances of individual patients.

Attendees will explore inspiring stories from peers who have leveraged FDB solutions to redefine medication decision-making and transform clinician workflows. From increasing medication alert acceptance, improving Leapfrog CPOE test scores, integrating real-time pharmacogenomic (PGx) decision support, boosting medication adherence, easing operational burden for nurses, and improving HCAHPS scores, to enabling drug price transparency for consumers, answering consumers' medication questions, and expediting development time—these success stories demonstrate meaningful impact.

Attendees will also learn how FDB solutions have been strategically advanced in the past year to further streamline workflows and deliver actionable, patient-specific medication decision support and personalized medication education information for patients when it matters most.

Featured success stories include the following:

Increasing Alert Acceptance & Improving Leapfrog CPOE Scores

Lehigh Valley Health Network (LVHN) implemented FDB Targeted Medication Warnings™ for hyperkalemia. Hyperkalemia alerts were reduced by 71% with greater than 60% alert acceptance. Read the LVHN Case Study.
NCH (Naples Comprehensive Health) implemented FDB Targeted Medication Warnings for hyperkalemia and QT prolongation alerts. Not only did their number of related drug-drug interaction alerts decrease by up to 37.5%, but they also experienced more alert acceptances, fewer alert overrides, and improved their Leapfrog CPOE test scores from 63% to 80%. Read the NCH Case Study.

Instead of delivering generalized medication alerts for all patients, FDB Targeted Medication Warnings, one of FDB's next-generation PatientFirst™ solutions, revolutionizes medication clinical decision support (CDS) by basing medication alerts on timely patient-specific data such as the most recent lab results, vital signs and clinical risk scores. Hospitals and health systems can optimize key alerts so that they are presented to clinicians only when pertinent to a patient's immediate care needs and current clinical context. This helps improve medication decision-making for better patient care and safety and increases alert acceptance by clinicians by making alerts more meaningful and actionable. It also helps reduce alert burden by reducing the number of generalized, non-actionable alerts to which clinicians must respond.

Integrating Real-Time Pharmacogenomic CDS to Inform More Effective Treatments

Ontario Shores Centre for Mental Health Sciences integrated FDB Pharmacogenomic CDS to provide real-time gene-drug interaction analysis, allowing for more personalized care and the precise optimization of treatment plans tailored to each patient's unique genetic profile. Read the Announcement.
Frederick Health started a precision medicine program in 2021. They utilized FDB Pharmacogenomic CDS to provide clinicians with the patient genetic testing results they need to make more precise medication decisions for each individual patient, rather than attempting to build and maintain the complex and evolving content themselves. Read the Announcement.

Also an FDB PatientFirst solution, FDB Pharmacogenomic CDS equips hospitals and health systems to extend this next generation of evidence-based, highly personalized care to more patients. The purpose-built solution enables health systems to seamlessly integrate actionable genomic guidance for appropriate drug therapy into clinicians' workflows in the electronic health record (EHR) without the need to leverage internal resources. This helps to reduce the potential for medication errors and ensures the effectiveness of treatments for each patient, which can improve outcomes and reduce hospital stays.

HIMSS25 Education Session About Integrating Advanced Genomics into the Workflow

HIMSS25 attendees can learn more about Frederick Health's experience first-hand during a presentation, "Expanding Use Cases for Genomics: A Precision Medicine Update," on Tuesday, March 4, 3:15 p.m. PST in Lido 3101 at the Venetian Convention & Expo Center. Patricia Rice, CRNP, RN, Clinical Director for Precision Medicine & Genetics at Frederick Health, and Jackie Rice, RN, Vice President and CIO, will discuss the health system's innovative precision medicine program, driving efficiency, insight integration, and expanding into precision nutrition, behavioral health, and clinical trials.

Customizing CDS to Quickly Reduce Medication Alert Volume

Parkview Health leveraged FDB AlertSpace® to drive proactive data-driven evaluations of medication alerts within its EHR, resulting in the elimination of nearly 9,000 or 17.3% of non-actionable drug-drug interaction alerts per week. Read the Parkview Health Case Study.

Analytics capabilities from FDB AlertSpace® provide health systems with automated insights into the most overridden medication-related alerts. This empowered Parkview Health to quickly identify areas for improvement and spend more time assessing each alert's appropriateness in Parkview's patient population. FDB AlertSpace also enabled the health system to tap into their clinicians' collective experience to collaboratively identify and customize medication alerts to make them more meaningful, intuitive, and actionable. This lessens alert fatigue among prescribers and pharmacists so they can better focus on patient care and improves clinician acceptance of computerized provider order entry (CPOE).

Boosting Medication Understanding & Adherence to Treatment Plans

In the first six months of their enterprise-wide implementation, ChristianaCare utilized simplified medication instructions from FDB's Meducation® Solution for more than 31,000 patients in 15 different languages to improve medication understanding and adherence.
Another major health system revolutionized their approach to complex medication education in their transplant unit with Meducation. Read the Case Study.

FDB's Meducation is a cloud-based solution that seamlessly integrates directly into a health system's EHR or pharmacy management system workflow. It streamlines updating and accessing medication lists by clinicians and enables caregivers to create and deliver highly personalized medication plans to all patients, including those with low health literacy, poor vision, or limited English proficiency. Meducation provides patient-specific medication instructions, written at a 5th to 8th grade reading level, with large font sizes, pictograms, explanatory videos, and an easy-to-understand consolidated medication calendar. These materials can be offered to patients in any of more than 31 languages.

Easing Operational Burden for Nurses, While Improving HCAHPS Scores

Northwestern Medicine leveraged FDB's new Meducation® Bedside solution to ease the operational burden and reduce clicks (from 5 clicks to 1) for their nurses during the bedside medication counseling process.

FDB's new Bedside Meducation solution automatically delivers the trusted simplified medication instructions from FDB's Meducation solution that patients received at discharge and during outpatient care to nurses in the EHR Medication Administration Record (MAR). With fewer clicks and less searching for information, nurses are equipped to discuss medications with patients at the point of administration, first verbally and then printed out if the patient requests it. By enhancing this important element of a patient's stay, hospitals can achieve increased patient satisfaction as reflected by improved performance on key-related communication questions on the Hospital Consumer Assessment of Healthcare Providers and Systems (HCAHPS). Better-informed patients also tend to be more adherent to care plans.

Enabling Drug Price Transparency for Consumers & Answering Their Medication Questions

The FDB Vela™ ePrescribing network introduces drug price transparency for consumers that is long overdue and supports Real Time Pharmacy Benefit (RTPB) regulatory mandates for prescribing and pharmacies. Read the Whitepaper.
Amazon Alexa helps answer consumer questions about medications. Read the Announcement.

Inconsistent real-time pharmacy benefit data and limited access to drug out-of-pocket cost information frequently hinder consumers' ability to make informed medication decisions. Despite technical advancements allowing consumers to compare costs for everyday items via computers or smartphones, accessing prescription drug pricing information remains elusive to patients. This can result in "sticker shock" at the pharmacy counter, which often leads to prescription abandonment. FDB envisions FDB Vela, a new cloud-native ePrescribing network, as a pivotal tool in improving price transparency by collaborating with consumer applications to deliver critical drug pricing information directly to patients before the prescription fulfillment process. The FDB Vela ePrescribing network enables the seamless flow of critical medication prescription information, benefits verification, and clinical decision support between prescribers, payers, and pharmacies. It also enables sharing of RTPB information across the network.

To further empower consumers, FDB's authoritative drug information provides specialized answers to consumers' questions about medication information, created specifically for Amazon Alexa's voice-enabled service.

Expediting Development Times

Aspen RxHealth decreased development timelines by 50% and saved significant upfront costs with FDB Cloud Connector™. Read the Aspen RxHealth Case Study.

As part of a population health initiative, Aspen RxHealth uses FDB's drug knowledge and analytics to support its pharmacist community in delivering safe and effective clinical pharmacy services and targeted interventions for at-risk health plan members. The company launched this capability in record time and with significantly less upfront cost by leveraging FDB Cloud Connector™, a web API solution for integrated medication decision support that enables users to access and deploy the latest drug knowledge in vastly reduced development timeframes.

Meet With FDB Representatives to Learn More:

The FDB team will be at booth #2835 in the HIMSS25 Exhibit Hall to answer attendees' questions and discuss transforming their organization's prescribing and fulfillment workflows with patient-centered, actionable guidance they can trust.

Book a meeting here.
Learn more about FDB Customer Success Stories here.

About FDB
FDB (First Databank) creates and delivers the world's most powerful drug knowledge that ignites, inspires, and illuminates critical medication decisions. We collaborate with our partners to help improve patient safety, operational efficiency, and health outcomes. Our drug databases drive healthcare information systems that serve the majority of hospitals, physician practices, pharmacies, payers, and all other areas of healthcare and are used by millions of clinicians, business associates, and patients every day. For a complete look at FDB's other solutions and services, please visit https://www.fdbhealth.com/, or follow us on LinkedIn and YouTube.

About Hearst Health
The mission of Hearst Health is to help guide the most important care moments by delivering vital information into the hands of everyone who touches a person's health journey. Care guidance from Hearst Health reaches the majority of people in the U.S. The Hearst Health network includes FDB (First Databank), Zynx Health, MCG, Homecare Homebase, MHK and QGenda. Hearst also holds a minority interest in the precision medicine and oncology analytics company Aster Insights. Follow Hearst Health on X @HearstHealth and LinkedIn @Hearst-Health.